title: Fatal cardiac incident after use of halofantrine.
authors.forename: D
authors.initials: D
authors.lastname: Malvy
authors.forename: M C
authors.initials: MC
authors.lastname: Receveur
authors.forename: P
authors.initials: P
authors.lastname: Ozon
authors.forename: F
authors.initials: F
authors.lastname: Djossou
authors.forename: P
authors.initials: P
authors.lastname: Le Metayer
authors.forename: J E
authors.initials: JE
authors.lastname: Touze
authors.forename: M
authors.initials: M
authors.lastname: Longy-Boursier
authors.forename: M
authors.initials: M
authors.lastname: Le Bras
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D004562:Electrocardiography; D005260:Female; D005602:France; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D010616:Phenanthrenes / Q000009:adverse effects*; D013019:South Africa; D014195:Travel
chemical_list: D000962:Antimalarials; D010616:Phenanthrenes; C023768:halofantrine